By: Björn

New members of the PAASP Advisory Board
May 22, 2019

We are delighted to announce that Dr. Rita Balice-Gordon and Dr. Phil Skolnick have joined PAASP’s Advisory Board:Rita Balice-Gordon, Ph.D., is…

Read More
Pilot implementation of the EQIPD Quality System
May 22, 2019

EQIPD (European Quality in Preclinical Data) is developing a flexible quality-management framework that aims to improve conduct and reporting of preclinical…

Read More
Replication Study: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
March 13, 2019

The Reproducibility Project: Cancer Biology aims to replicate a number of landmark studies in the field of tumor biology published between 2010 –…

Read More
Newsletter March 2019
March 11, 2019

PAASP News: PAASP moves across the Atlantic! LINK PAASP US has won the NIH/NIDA Challenge Award LINK Thank you, Bruce! Welcome,…

Read More
Thank you, Bruce! Welcome, Glenn!
March 11, 2019

As many of our readers already know, our dear colleague and advisor, Bruce Altevogt, moved on to take a new and…

Read More
The US team has won the 6th NIH/NIDA Challenge Award
March 11, 2019

In December 2018, the National Institute on Drug Abuse (NIDA) initiated its sixth annual Challenge competition with the aim to solicit…

Read More
PAASP moves across the Atlantic!
March 11, 2019

We have always enjoyed our connections to peers in the US and the support from our US-based advisors, but have felt…

Read More
Death is certain, the time is not
March 11, 2019

Finally, the first scientific study to examine the mortality and survival in Game of Throneshas been published (LINK). The authors found that…

Read More
Within-subject study designs: Latin Square?
March 11, 2019

In within-subject study designs (also known as the cross-over), subjects may be given sequences of treatments with the intent of studying…

Read More
Something is rotten in the state of antibody quality
March 11, 2019

A team of researchers led by Eleftherios P. Diamandis at the University of Toronto set out to discover novel serological markers…

Read More